McKesson PT Raised to $220.00 at Raymond James (MCK)
Raymond James raised their price target on shares of McKesson (NYSE:MCK) from $210.00 to $220.00 in a research note issued on Tuesday. Raymond James’ target price suggests a potential upside of 16.12% from the company’s current price.
Several other analysts have also recently commented on the stock. Analysts at Morgan Stanley reiterated an “overweight” rating on shares of McKesson in a research note on Thursday, June 26th. They now have a $205.00 price target on the stock, up previously from $197.00. Separately, analysts at FBR Capital Markets raised their price target on shares of McKesson from $192.00 to $200.00 in a research note on Thursday, June 26th. They now have an “outperform” rating on the stock. Finally, analysts at Mizuho raised their price target on shares of McKesson from $199.00 to $205.00 in a research note on Thursday, June 26th. They now have a “buy” rating on the stock. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $198.31.
Shares of McKesson (NYSE:MCK) traded up 1.75% during mid-day trading on Tuesday, hitting $189.46. 1,447,992 shares of the company’s stock traded hands. McKesson has a 52-week low of $113.26 and a 52-week high of $192.03. The stock’s 50-day moving average is $185.0 and its 200-day moving average is $175.1. The company has a market cap of $43.685 billion and a price-to-earnings ratio of 34.37.
McKesson (NYSE:MCK) last announced its earnings results on Monday, May 12th. The company reported $2.55 earnings per share for the quarter, beating the analysts’ consensus estimate of $2.40 by $0.15. The company had revenue of $38.14 billion for the quarter, compared to the consensus estimate of $35.89 billion. During the same quarter last year, the company posted $1.45 earnings per share. McKesson’s revenue was up 25.0% compared to the same quarter last year. Analysts expect that McKesson will post $10.66 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Tuesday, July 1st. Investors of record on Monday, June 9th will be given a dividend of $0.24 per share. This represents a $0.96 dividend on an annualized basis and a yield of 0.51%. The ex-dividend date of this dividend is Thursday, June 5th.
McKesson Corporation delivers pharmaceuticals, medical supplies and healthcare information technologies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.